Get startedLog in
    Picture of Sichuan Kelun-Biotech Biopharmaceutical Co logo

    6990 — Sichuan Kelun-Biotech Biopharmaceutical Co Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Sichuan Kelun-Biotech Biopharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-890-567-468-143-356
    Depreciation
    Amortisation
    Non-Cash Items102195177103190
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital27934.5276-481-115
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-486-27159.6-430-180
    Capital Expenditures-94.7-39-82.3-81.1-126
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.3596.84-943-741537
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities-94.4-32.1-1,025-822411
    Financing Cash Flow Items-40-2.93-10-2.29-6.16
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities6473132,3821,0371,728
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash65.611.21,436-1921,907